The Venture Codex

Company Details

GRO Biosciences

750 Main St, Cambridge, MA, 02139, United States

Overview

Developing advanced protein therapeutics using synthetic biology.

Total Raised

$87 M

Rounds

3

Links

Verticals

Biotechnology

Health Diagnostics

Medical

Pharmaceutical

Therapeutics

Investment History

Series B
Jul 2024
$60M
Atlas Venture · Lead Redmile Group Digitalis Ventures Leaps by Bayer Innovation Endeavors Access Biotechnology · Lead
Series A
Nov 2021
$25M
Digitalis Ventures Innovation Endeavors Redmile Group · Lead Leaps by Bayer · Lead
Seed
Sep 2017
$2M
Innovation Endeavors Digitalis Ventures · Lead

Team

Daniel J. Mandell

Co-Founder and Chief Executive Officer

Benjamin Stranges

Principal Scientist

Ross Thyer

Co-Founder and Scientific Advisor

Christopher Gregg

Chief Science Officer, Co-Founder, Director